Matches in Wikidata for { <http://www.wikidata.org/entity/Q94476940> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q94476940 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q94476940 description "scientific article published on 30 April 2020" @default.
- Q94476940 description "wetenschappelijk artikel" @default.
- Q94476940 description "наукова стаття, опублікована 30 квітня 2020" @default.
- Q94476940 name "Post-Marketing Pooled Safety Analysis for CT-P13 Treatment of Patients with Immune-Mediated Inflammatory Diseases in Observational Cohort Studies" @default.
- Q94476940 name "Post-Marketing Pooled Safety Analysis for CT-P13 Treatment of Patients with Immune-Mediated Inflammatory Diseases in Observational Cohort Studies" @default.
- Q94476940 type Item @default.
- Q94476940 label "Post-Marketing Pooled Safety Analysis for CT-P13 Treatment of Patients with Immune-Mediated Inflammatory Diseases in Observational Cohort Studies" @default.
- Q94476940 label "Post-Marketing Pooled Safety Analysis for CT-P13 Treatment of Patients with Immune-Mediated Inflammatory Diseases in Observational Cohort Studies" @default.
- Q94476940 prefLabel "Post-Marketing Pooled Safety Analysis for CT-P13 Treatment of Patients with Immune-Mediated Inflammatory Diseases in Observational Cohort Studies" @default.
- Q94476940 prefLabel "Post-Marketing Pooled Safety Analysis for CT-P13 Treatment of Patients with Immune-Mediated Inflammatory Diseases in Observational Cohort Studies" @default.
- Q94476940 P1433 Q94476940-A8242326-C240-41D9-ABDA-1626AF983E48 @default.
- Q94476940 P1476 Q94476940-BA0B4F92-B0E8-480E-B6CF-2C0DF0BC24A1 @default.
- Q94476940 P2093 Q94476940-D3EBBAA1-312C-4D8F-98F8-4BB22B1127BF @default.
- Q94476940 P2093 Q94476940-F6E2B4C4-4641-48FC-B4DE-74C0D0EA7873 @default.
- Q94476940 P31 Q94476940-42E3EC38-6974-41EC-8889-6B28B6A6B4F8 @default.
- Q94476940 P356 Q94476940-049DE6F9-6255-41A3-BF92-3EC22860A25D @default.
- Q94476940 P50 Q94476940-1678D8B2-E61D-40E4-9BBC-F7F2119D121E @default.
- Q94476940 P50 Q94476940-9D186A4E-9594-44D1-8969-963EE248FDF0 @default.
- Q94476940 P50 Q94476940-E4209897-B4EF-40AA-8526-4BD2FC01C099 @default.
- Q94476940 P50 Q94476940-E4B2C0A9-08AC-49CC-BB11-18863FD18091 @default.
- Q94476940 P577 Q94476940-2A6B3E41-E85A-4F84-973C-5BF9AA73C4AC @default.
- Q94476940 P698 Q94476940-0E0E8EAD-5E4D-40B5-AD1A-3BA896B96B7A @default.
- Q94476940 P932 Q94476940-973F2768-7AEF-42BF-B165-BC43FB1AE7B6 @default.
- Q94476940 P356 S40259-020-00421-2 @default.
- Q94476940 P698 32356239 @default.
- Q94476940 P1433 Q4914612 @default.
- Q94476940 P1476 "Post-Marketing Pooled Safety Analysis for CT-P13 Treatment of Patients with Immune-Mediated Inflammatory Diseases in Observational Cohort Studies" @default.
- Q94476940 P2093 "Seul Gi Lee" @default.
- Q94476940 P2093 "Sujin Lee" @default.
- Q94476940 P31 Q13442814 @default.
- Q94476940 P356 "10.1007/S40259-020-00421-2" @default.
- Q94476940 P50 Q89775421 @default.
- Q94476940 P50 Q89863826 @default.
- Q94476940 P50 Q94476938 @default.
- Q94476940 P50 Q94476939 @default.
- Q94476940 P577 "2020-04-30T00:00:00Z" @default.
- Q94476940 P698 "32356239" @default.
- Q94476940 P932 "7223987" @default.